Global Surgical Site Infection Control Market to Reach US$ 6.5 Billion by 2032, Propelled by Rising Prevalence of Chronic Conditions

March 15, 2023 | Healthcare

IMARC Group's latest report, titled "Surgical Site Infection Control Market Report by Product (Antibiotic Prophylaxis Products, Wound Care Dressings, Surgical Drapes, Surgical Clippers, Antiseptics and Disinfectants, Wound Irrigation Products, and Others), Infection Type (Superficial Incisional SSI, Deep Incisional SSI, Organ or Space SSI), Surgery Type (Cesarean Section, Gastric Bypass, Cataract Surgery, Dental Restoration, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032", finds that the global surgical site infection control market size reached US$ 4.6 Billion in 2023. Surgical site infection (SSI) control comprises various measures and practices implemented in healthcare settings to prevent infections among patients during their hospital stay, particularly after surgery in the operated part of the body. These infections can lead to prolonged treatment stays and hinder surgical wound healing. It is essential to implement SSI control as infections can cause severe damage to organs, tissues, or implants. Hospitals often use a range of SSI control products, such as surgical drapes, gloves, disinfectants, skin preparation solutions, scrubs, hair covers, and medical nonwovens. Currently, SSI control finds extensive applications in the healthcare industry due to its ability to prevent infections, enhance patient care quality, and improve surgical outcomes and success rates.

Global Surgical Site Infection Control Market Trends:

The rising prevalence of chronic conditions, such as cancer, gastrointestinal disorders, and cardiovascular diseases (CVDs), owing to unhealthy lifestyle habits and an aging population, represents the primary factor driving the market growth. In addition, the surging number of hospital admissions is propelling the market growth. Moreover, SSI control products offer several benefits, including reducing hospital stays, minimizing patient discomfort, and eliminating the need for revision surgeries. In line with this, the increasing instances of hospital-acquired infections (HAIs) are positively influencing the market growth. Additionally, the rising awareness regarding SSIs and the growing focus on infection prevention through proper control measures have catalyzed market growth. Besides this, several favorable initiatives by numerous governmental and non-governmental agencies, such as the introduction of stringent guidelines and training programs focused on infection control practices, are other major growth-inducing factors. Furthermore, the integration of SSI control products with advanced technologies is contributing to market growth. Other factors, including ongoing research and development (R&D) activities, an increasing number of patients undergoing surgical procedures, and improving healthcare infrastructure, are also anticipated to create a positive market outlook. Looking forward, IMARC Group expects the market value to reach US$ 6.5 Billion by 2032, expanding at a CAGR of 3.78% during 2024-2032.

Market Summary:

  • Based on the product, the market has been divided into antibiotic prophylaxis products, wound care dressings, surgical drapes, surgical clippers, antiseptics and disinfectants, wound irrigation products, and others. 
  • On the basis of the infection type, the market has been categorized into superficial incisional, deep incisional, and organ or space SSI. 
  • The market has been segmented based on the surgery type into cesarean section, gastric bypass, cataract surgery, dental restoration, and others.
  • Based on the end user, the market has been classified into hospitals, ambulatory surgical centers, and others.
  • Region-wise, the market has been segregated into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others) and Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being 3M Company, Ansell Limited, Becton Dickinson and Company, bioMerieux SA (Institut Mérieux), Covalon Technologies Ltd., GAMA Healthcare Ltd., Getinge AB (Carl Bennet AB), Johnson & Johnson, Kimberly-Clark Corporation, Mölnlycke Health Care AB, Prescient Surgical, and Steris Corporation.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product, Infection Type, Surgery Type, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 3M Company, Ansell Limited, Becton Dickinson and Company, bioMerieux SA. (Institut Mérieux), Covalon Technologies Ltd., GAMA Healthcare Ltd., Getinge AB (Carl Bennet AB), Johnson & Johnson, Kimberly-Clark Corporation, Mölnlycke Health Care AB, Prescient Surgical, Steris Corporation.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N A
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Surgical Site Infection Control Market to Reach US$ 6.5 Billion by 2032, Propelled by Rising Prevalence of Chronic Conditions
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More